Ligand Pharmaceuticals Incorporateds Intrinsic Value Is Potentially 99 percent Above Its Share Price
CCASX Fund | USD 83.36 0.46 0.55% |
Slightly above 62% of Conestoga Small's investor base is looking to short. The analysis of overall sentiment of trading Conestoga Small Cap mutual fund suggests that many investors are alarmed at this time. Conestoga Small's investing sentiment can be driven by a variety of factors including economic data, Conestoga Small's earnings reports, geopolitical events, and overall market trends.
Conestoga |
Key Insights Using the 2 Stage Free Cash Flow to Equity, Ligand Pharmaceuticals fair value estimate is US259 Ligand...
Read at finance.yahoo.com
Conestoga Small Fundamental Analysis
We analyze Conestoga Small's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Conestoga Small using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Conestoga Small based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Conestoga Small is currently under evaluation in net asset among similar funds. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Conestoga Small Cap Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Conestoga Small mutual fund to make a market-neutral strategy. Peer analysis of Conestoga Small could also be used in its relative valuation, which is a method of valuing Conestoga Small by comparing valuation metrics with similar companies.
Peers
Conestoga Small Related Equities
TADGX | T Rowe | 0.36 | ||||
FIDGX | Fidelity Small | 0.19 | ||||
CIPNX | Champlain Small | 0.27 | ||||
TQAIX | T Rowe | 0.56 | ||||
PSGCX | Virtus Kar | 0.69 |
Other Information on Investing in Conestoga Mutual Fund
Conestoga Small financial ratios help investors to determine whether Conestoga Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Conestoga with respect to the benefits of owning Conestoga Small security.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |